↑ 薬物リストへ　← 戻る

Hcq/cq and cab combined treatment    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
74下垂体性PRL分泌亢進症1

74. 下垂体性PRL分泌亢進症　［臨床試験数：18，薬物数：33（DrugBank：10），標的遺伝子数：16，標的パスウェイ数：63］
Searched query = "Prolactin secreting pituitary adenoma", "Pituitary PRL secretion hyperthyroidism", "Prolactinoma", "Prolactin secreting adenoma"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 18 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03400865
(ClinicalTrials.gov)		October 25, 20188/1/2018Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant ProlactinomasThe Effect of Combined Treatment of Cabergoline With Hydroxychloroquine/Chloroquine for Resistant ProlactinomasResistance, Disease;ProlactinomaDrug: HCQ/CQ and CAB combined treatmentZhebao WuXinqiao Hospital of Chongqing;First Hospital of China Medical University;Beijing Tiantan Hospital;First Affiliated Hospital of Wenzhou Medical University;First Affiliated Hospital of Fujian Medical University;Peking Union Medical College Hospital;Huashan Hospital;Chinese PLA General HospitalNot yet recruiting18 Years70 YearsAll30N/AChina